Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials

Completed

Conditions studied: Alzheimer Disease, Cognition Disorders

In brief

This registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in being contacted for an Eli Lilly and Company (Lilly) Alzheimer's Disease drug research trial.

Key facts

Study ID
NCT02918539
Run by
Avid Radiopharmaceuticals
People needed
317
Starts
2016-10-01
Expected to finish
2017-10-18
Last updated by the study team
2018-10-24

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.